Join
Live feed
·
INSIDERFilingvia Quantisnow
Acumen Pharmaceuticals Inc. logo

Director Stoppel Laura was granted 35,500 shares (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
ABOS· Acumen Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ABOS (Acumen Pharmaceuticals Inc.) and more on Quantisnow.

Director Stoppel Laura was granted 35,500 shares (SEC Form 4) | Quantisnow